Century Therapeutics, Inc. (IPSC)

NASDAQ: IPSC · Real-Time Price · USD

1.790

-0.140 (-7.25%)

At close: Feb 11, 2026, 4:00 PM EST

1.800

+0.010 (0.56%)

After-hours: Feb 11, 2026, 6:11 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Allogeneic Cell Therapies	6.59M
Allogeneic Cell Therapies Growth	194.81%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
United States	6.59M
United States Growth	194.81%